You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0447 Regulation of Serum Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases-1 following Rituximab Therapy in Patients with Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Blockers

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - other biologic treatment
AB0447 Regulation of Serum Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases-1 following Rituximab Therapy in Patients with Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Blockers

 

Online download statistics by month:

Online download statistics by month: June 2014 to January 2024

AbstractFullPdf
Jun 20141000
Jul 20141200
Aug 2014201
Sep 20141601
Oct 2014400
Nov 2014600
Dec 20141001
Jan 2015800
Feb 2015300
Mar 2015401
Apr 2015400
May 2015500
Jun 2015200
Jul 2015300
Aug 2015300
Sep 2015300
Oct 2015100
Nov 2015603
Dec 2015700
Jan 2016600
Feb 2016100
Mar 2016300
Apr 20169011
May 2016300
Jun 2016801
Jul 2016400
Aug 2016300
Sep 20161000
Oct 2016700
Nov 2016500
Dec 2016500
Jan 20171100
Feb 2017200
Mar 20171000
Apr 20171201
May 2017500
Jun 2017400
Jul 2017400
Aug 20171000
Sep 2017800
Oct 2017200
Nov 2017200
Dec 20171200
Jan 20181200
Feb 2018400
Mar 20181000
Apr 2018800
May 20181801
Jul 2018800
Aug 20181000
Sep 2018600
Oct 2018400
Nov 2018200
Mar 2019400
Apr 2019200
May 2019200
Jul 2019400
Oct 20191000
Feb 2020400
Jul 2020200
Sep 2020800
Oct 2020200
Nov 2020200
Dec 2020200
Feb 2021200
Jul 2021200
Oct 2021400
Nov 2021500
Dec 2021900
Feb 2022200
Mar 2022300
Apr 20226800
May 2022600
Jul 20221200
Aug 2022400
Sep 2022200
Oct 2022600
Nov 2022200
Dec 2022800
Feb 2023200
Mar 2023500
May 2023600
Jun 2023200
Jul 2023400
Aug 2023400
Sep 2023400
Nov 2023200
Dec 2023800
Jan 20241400
Total565021